Cancer research: Horizon Europe deal delay is causing UK “brain drain,” researchers warn

The delay in securing a post-Brexit research funding deal between the UK and European Union has “damaged” the UK’s reputation and led to researchers leaving the country to take up more attractive offers, leaders in cancer research have warned.

Access to Horizon Europe—a research and innovation funding programme with an £81bn budget—was agreed as part of the Brexit agreement, but ran into difficulty when the …